Cephas Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.36 Cr
as on 05-12-2024
- Paid Up Capital ₹ 1.36 Cr
as on 05-12-2024
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.43 Cr
as on 05-12-2024
- Revenue 290.05%
(FY 2021)
- Profit 110.40%
(FY 2021)
- Ebitda -223.99%
(FY 2021)
- Net Worth 0.68%
(FY 2021)
- Total Assets 28.08%
(FY 2021)
About Cephas Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.36 Cr and a paid-up capital of Rs 1.36 Cr.
The company currently has active open charges totaling ₹5.43 Cr.
Rajakumari Singh, Thangiah Immanuel, and Benjamin Karunakaran serve as directors at the Company.
- CIN/LLPIN
U73100TN2019PTC130646
- Company No.
130646
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cephas Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajakumari Singh  | Director | 22-Jul-2019 | Current |
| Thangiah Immanuel | Director | 22-Jul-2019 | Current |
| Benjamin Karunakaran | Whole-Time Director | 22-Jul-2019 | Current |
Financial Performance of Cephas Life Sciences.
Cephas Life Sciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 290.05% increase. The company also saw a substantial improvement in profitability, with a 110.4% increase in profit. The company's net worth moved up by a moderate rise of 0.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cephas Life Sciences?
In 2021, Cephas Life Sciences had a promoter holding of 17.29% and a public holding of 82.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cephas Medical Private LimitedActive 24 years 10 monthsRajakumari Singh and Thangiah Immanuel are mutual person
Cephlan Private LimitedActive 1 year 5 monthsRajakumari Singh and Thangiah Immanuel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 31 Jul 2024 | ₹5.00 M | Open |
Sidbi Creation Date: 08 Feb 2022 | ₹2.84 M | Open |
Indian Bank Creation Date: 16 Nov 2020 | ₹1.50 Cr | Open |
How Many Employees Work at Cephas Life Sciences?
Cephas Life Sciences has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cephas Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cephas Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
